1
Kuhrts Eric: Anti-inflammatory cyclooxygenase-2 selective inhibitors. Lipoprotein Technologies, Kuhrts Eric, WESTERN M Wayne, July 29, 2004: WO/2004/062611 (17 worldwide citation)

Disclosed is a novel anti-inflammatory pharmaceutical composition that exhibits potent and selective inhibition of the cycloooxygenase-2 (COX-2) enzyme. The formulation includes of a hops extract that exhibits COX-2 selectivity as defined by dividing the IC50 COX-2/ IC5o COX-1 concentrations that ar ...


2
Xiong Weihong, Patel Dinesh C: An effervescent green tea extract formulation. Xel Herbaceuticals, WESTERN M Wayne, January 4, 2001: WO/2001/000038 (11 worldwide citation)

A solid state water soluble formulation in granular or tablet form is provided. The formulation is a natural products formulation containing a green tea plant extract in combination with other ingredients which create an effervescent liquid composition upon dispensing the formulation in a liquid. Th ...


3
Cho Hyun Sam, Han Kyung Ryul, Song Ki Jeon: Double-sided and multi-layered pcbn and pcd abrasive articles. Cho Hyun Sam, Han Kyung Ryul, Song Ki Jeon, WESTERN M WAYNE, September 21, 2006: WO/2006/099194 (10 worldwide citation)

A double-sided PCBN and/or PCD compact can be produced using high pressure high temperature processes allowing for increased effective thickness of abrasive tools, decreased delamination, and increased useful service life. A poly crystalline compact can include a substrate (12) having a first surfac ...


4
Chen Feng Jing, Patel Mahesh V, Fikstad David T, Zhang Huiping, Giliyar Chandrashekar: Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs. Lipocine, Chen Feng Jing, Patel Mahesh V, Fikstad David T, Zhang Huiping, Giliyar Chandrashekar, WESTERN M Wayne, December 9, 2004: WO/2004/105694 (9 worldwide citation)

Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs, particularly steroids, are provided. The pharmaceutical compositions include a therapeutically effective amount of a hydrophobic drug, preferably a steroid; a solubilizer, preferably a vitamin E substance; and a su ...


5
Wang Dong, Miller Scott C, Kopeckova Pavla, Kopecek Jindrich: Water-soluble polymeric bone-targeting drug delivery system. University Of Utah, Wang Dong, Miller Scott C, Kopeckova Pavla, Kopecek Jindrich, WESTERN M Wayne, July 29, 2004: WO/2004/062588 (8 worldwide citation)

The present invention provides bone-targeting polymeric drug delivery systems based on HPMA and related copolymers and methods of making thereof. The water-soluble bone-targeting polymeric conjugates of the present invention comprise water-soluble copolymer backbones (P) which are linked, via a firs ...


6
Chen Feng Jing, Patel Mahesh V: Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent. Lipocine, Chen Feng Jing, Patel Mahesh V, WESTERN M Wayne, October 14, 2004: WO/2004/087052 (7 worldwide citation)

The present invention relates to oral pharmaceutical compositions and methods for improved delivery of therapeutic agents, e.g., lipid-regulating agents. Compositions of the present invention include a carrier, where the carrier contains a combination of a triglyceride and at least two surfactants, ...


7
Hong Pk Andy: Pressurizing-depressurizing cycles for removal of contaminants in environmental samples. University Of Utah Research Foundation, Hong Pk Andy, WESTERN M Wayne, October 25, 2007: WO/2007/120735 (6 worldwide citation)

A method of removing contaminants from slurry samples is set forth. The method includes the utilization of repeated pressurizing and depressurizing steps to disrupt solidified particles in solid-containing slurries thereby increasing decontamination efficiency. An expansion fluid is injected into th ...


8
Mahato Ram I, Han Sang Oh, Furgeson Darin Y, Anwer Khursheed: A novel cationic lipopolymer as a biocompatible gene delivery agent. Expression Genetics, Mahato Ram I, Han Sang Oh, Furgeson Darin Y, Anwer Khursheed, WESTERN M Wayne, July 7, 2005: WO/2005/060934 (5 worldwide citation)

A biodegradable cationic lipopolymer comprising a polyethylenimine (PEI), a lipid, and a biocompatible hydrophilic polymer, wherein 1) the lipid and the biocompatible hydrophilic polymer are directly linked to the PEI backbone or 2) the lipid is linked to the PEI backbone through the biocompatible h ...


9
Sung Chien Min: Semiconductor-on-diamond devices and methods of forming. Sung Chien Min, WESTERN M Wayne, December 22, 2005: WO/2005/122284 (4 worldwide citation)

The present invention provides semiconductor-on-diamond devices (200), and methods for the formation thereof. In one aspect, a mold (220) is provided which has an interface surface (212) configured to inversely match a configuration intended for the device surface (210) of a diamond layer (204). An ...


10
Sanders Steven W, Ebert Charles D: Compositions and methods for transdermal oxybutynin therapy. Watson Pharmaceuticals, Sanders Steven W, Ebert Charles D, WESTERN M Wayne, May 21, 2004: WO/2004/041188 (3 worldwide citation)

The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy. In one aspect, these compositions and methods provide a lower plasma concentration of oxybutynin metabol ...